About GMI
What GMI and eExo-GMI® are, and the external identifiers that anchor them across the scientific and regulatory record.
GMI — Ganoderma microsporum immunomodulatory protein
A fungal immunomodulatory protein (FIP) from Ganoderma microsporum, produced recombinantly in Pichia pastoris. In the scientific and patent literature for over 20 years; registered as a food, cosmetic and drug-substance ingredient in multiple jurisdictions.
Also known as: GMI、FIP-gmi、GMIP、Fungal immunomodulatory protein from Ganoderma microsporum、小孢子靈芝免疫調節蛋白、小孢子靈芝類球蛋白、Pichia r-Ganoderma Microsporum Polypeptide-1 Ferment Filtrate Extract
Identifiers
| Wikidata | Q110625259 |
|---|---|
| UniProt | E7FH75 |
| PDB | 3KCW |
| GenBank | AGU04723.1 |
| PubChem SID | 461501955 |
| NCI NSC | NSC767593 |
| US PCPC INCI | 35581 |
| EU COSING | 99091 |
| Japan JCIA | 567713 |
| US FDA NDI | 1133 |
eExo-GMI® — GMI encapsulated in Pichia extracellular vesicles
GMI encapsulated in Pichia (yeast) extracellular vesicles — a distinct derivative formulation of GMI, developed primarily for cosmetic applications.
Also known as: eExo-GMI®、Pichia/Ganoderma Microsporum Polypeptide-1 Extracellular Vesicles、霊芝外泌體